Johnson Johnson Correlations

JNJ Stock  USD 152.19  0.87  0.57%   
The current 90-days correlation between Johnson Johnson and Merck Company is 0.56 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Johnson Johnson moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Johnson Johnson moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Johnson Johnson Correlation With Market

Modest diversification

The correlation between Johnson Johnson and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.

Moving together with Johnson Stock

  0.63DRMA Dermata TherapeuticsPairCorr
  0.66BMY Bristol Myers SquibbPairCorr
  0.62LLY Eli LillyPairCorr
  0.74MRK Merck CompanyPairCorr
  0.66PFE Pfizer IncPairCorr
  0.68ABBV AbbVie IncPairCorr
  0.61ADTX Aditxt IncPairCorr
  0.7AMGN Amgen IncPairCorr
  0.64SSY SunLink Health SystemsPairCorr

Moving against Johnson Stock

  0.39NHC National HealthCarePairCorr
  0.33EHC Encompass Health CorpPairCorr
  0.6SSNLF Samsung ElectronicsPairCorr
  0.43AMRUTANJAN Amrutanjan Health CarePairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Johnson Stock performing well and Johnson Johnson Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Johnson Johnson's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.